Morbidity and mortality associated with prescription cannabinoid drug use in COPD.
Nicholas T VozorisPriscila PequenoPing LiPeter C AustinAnne L StephensonDenis E O'DonnellSudeep S GillAndrea S GershonPaula A RochonPublished in: Thorax (2020)
New cannabinoid use was associated with elevated rates of adverse outcomes among older adults with COPD. Although further research is needed to confirm these observations, our findings should be considered in decisions to use cannabinoids among older adults with COPD.